275 related articles for article (PubMed ID: 22469755)
1. T-type voltage-activated calcium channel Cav3.1, but not Cav3.2, is involved in the inhibition of proliferation and apoptosis in MCF-7 human breast cancer cells.
Ohkubo T; Yamazaki J
Int J Oncol; 2012 Jul; 41(1):267-75. PubMed ID: 22469755
[TBL] [Abstract][Full Text] [Related]
2. The CaV3.1 T-type Ca2+channel contributes to voltage-dependent calcium currents in rat outer hair cells.
Inagaki A; Ugawa S; Yamamura H; Murakami S; Shimada S
Brain Res; 2008 Mar; 1201():68-77. PubMed ID: 18294617
[TBL] [Abstract][Full Text] [Related]
3. Epigallocatechin-3-gallate elicits Ca2+ spike in MCF-7 breast cancer cells: essential role of Cav3.2 channels.
Ranzato E; Magnelli V; Martinotti S; Waheed Z; Cain SM; Snutch TP; Marchetti C; Burlando B
Cell Calcium; 2014 Oct; 56(4):285-95. PubMed ID: 25260713
[TBL] [Abstract][Full Text] [Related]
4. T-type calcium channels and tumor proliferation.
Panner A; Wurster RD
Cell Calcium; 2006 Aug; 40(2):253-9. PubMed ID: 16765439
[TBL] [Abstract][Full Text] [Related]
5. T-type CaV3.3 calcium channels produce spontaneous low-threshold action potentials and intracellular calcium oscillations.
Chevalier M; Lory P; Mironneau C; Macrez N; Quignard JF
Eur J Neurosci; 2006 May; 23(9):2321-9. PubMed ID: 16706840
[TBL] [Abstract][Full Text] [Related]
6. The role of voltage gated T-type Ca2+ channel isoforms in mediating "capacitative" Ca2+ entry in cancer cells.
Gray LS; Perez-Reyes E; Gomora JC; Haverstick DM; Shattock M; McLatchie L; Harper J; Brooks G; Heady T; Macdonald TL
Cell Calcium; 2004 Dec; 36(6):489-97. PubMed ID: 15488598
[TBL] [Abstract][Full Text] [Related]
7. [Impact of calcium channel antagonists for estrogen action on the endometrial carcinoma HEC-1A cells].
Bao XX; Wang JL; Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2012 Mar; 47(3):212-7. PubMed ID: 22781074
[TBL] [Abstract][Full Text] [Related]
8. Cav3.1 (alpha1G) T-type Ca2+ channels mediate vaso-occlusion of sickled erythrocytes in lung microcirculation.
Wu S; Haynes J; Taylor JT; Obiako BO; Stubbs JR; Li M; Stevens T
Circ Res; 2003 Aug; 93(4):346-53. PubMed ID: 12869394
[TBL] [Abstract][Full Text] [Related]
9. The roles of T-type calcium channel in the development of neuropathic pain following chronic compression of rat dorsal root ganglia.
Wen XJ; Xu SY; Chen ZX; Yang CX; Liang H; Li H
Pharmacology; 2010; 85(5):295-300. PubMed ID: 20453553
[TBL] [Abstract][Full Text] [Related]
10. Blockade of T-type voltage-dependent Ca2+ channels by benidipine, a dihydropyridine calcium channel blocker, inhibits aldosterone production in human adrenocortical cell line NCI-H295R.
Akizuki O; Inayoshi A; Kitayama T; Yao K; Shirakura S; Sasaki K; Kusaka H; Matsubara M
Eur J Pharmacol; 2008 Apr; 584(2-3):424-34. PubMed ID: 18331727
[TBL] [Abstract][Full Text] [Related]
11. Calcium channel gamma6 subunits are unique modulators of low voltage-activated (Cav3.1) calcium current.
Hansen JP; Chen RS; Larsen JK; Chu PJ; Janes DM; Weis KE; Best PM
J Mol Cell Cardiol; 2004 Dec; 37(6):1147-58. PubMed ID: 15572045
[TBL] [Abstract][Full Text] [Related]
12. T-type calcium channel trigger p21ras signaling pathway to ERK in Cav3.1-expressed HEK293 cells.
Choi J; Park JH; Kwon OY; Kim S; Chung JH; Lim DS; Kim KS; Rhim H; Han YS
Brain Res; 2005 Aug; 1054(1):22-9. PubMed ID: 16054119
[TBL] [Abstract][Full Text] [Related]
13. A role for voltage gated T-type calcium channels in mediating "capacitative" calcium entry?
Gackière F; Bidaux G; Lory P; Prevarskaya N; Mariot P
Cell Calcium; 2006 Apr; 39(4):357-66. PubMed ID: 16442617
[TBL] [Abstract][Full Text] [Related]
14. Hyperalgesia induced by spinal and peripheral hydrogen sulfide: evidence for involvement of Cav3.2 T-type calcium channels.
Maeda Y; Aoki Y; Sekiguchi F; Matsunami M; Takahashi T; Nishikawa H; Kawabata A
Pain; 2009 Mar; 142(1-2):127-32. PubMed ID: 19167819
[TBL] [Abstract][Full Text] [Related]
15. Ca2+ flux through voltage-gated channels with flow cessation in pulmonary microvascular endothelial cells.
Wei Z; Manevich Y; Al-Mehdi AB; Chatterjee S; Fisher AB
Microcirculation; 2004 Sep; 11(6):517-26. PubMed ID: 15371132
[TBL] [Abstract][Full Text] [Related]
16. Biophysics and structure-function relationship of T-type Ca2+ channels.
Talavera K; Nilius B
Cell Calcium; 2006 Aug; 40(2):97-114. PubMed ID: 16777221
[TBL] [Abstract][Full Text] [Related]
17. Low-voltage-activated (T-type) calcium channels control proliferation of human pulmonary artery myocytes.
Rodman DM; Reese K; Harral J; Fouty B; Wu S; West J; Hoedt-Miller M; Tada Y; Li KX; Cool C; Fagan K; Cribbs L
Circ Res; 2005 Apr; 96(8):864-72. PubMed ID: 15774856
[TBL] [Abstract][Full Text] [Related]
18. Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells.
Dong K; Wang R; Wang X; Lin F; Shen JJ; Gao P; Zhang HZ
Breast Cancer Res Treat; 2009 Feb; 113(3):443-56. PubMed ID: 18327707
[TBL] [Abstract][Full Text] [Related]
19. Molecular physiology of low-voltage-activated t-type calcium channels.
Perez-Reyes E
Physiol Rev; 2003 Jan; 83(1):117-61. PubMed ID: 12506128
[TBL] [Abstract][Full Text] [Related]
20. T-type calcium channel blockers inhibit autophagy and promote apoptosis of malignant melanoma cells.
Das A; Pushparaj C; Herreros J; Nager M; Vilella R; Portero M; Pamplona R; Matias-Guiu X; Martí RM; Cantí C
Pigment Cell Melanoma Res; 2013 Nov; 26(6):874-85. PubMed ID: 23931340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]